Concepedia

Pamela Perry

PP

19

Publications

1.3K

Citations

16

H-Index

2004

Active since

Affiliations

Otsuka (United States)(Current)

Otsuka (Japan)

Lundbeck (Denmark)

Zucker Hillside Hospital

Pharmaceutical Product Development (United States)

Pamela Perry is an author at Otsuka (United States) specializing in pharmacotherapy, psychiatry, and medicine.

ORCID

Top concepts

Publications per year

2004–2023

19

Publications

19

Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia

John M. Kane, Raymond Sanchez, Pamela Perry et al. · The Journal of Clinical Psychiatry · 2012 · 356 citations · Full text

Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study

W. Wolfgang Fleischhacker, Raymond Sanchez, Pamela Perry et al. · The British Journal of Psychiatry · 2014 · 151 citations · Full text

Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder

Joseph R. Calabrese, Raymond Sanchez, Na Jin et al. · The Journal of Clinical Psychiatry · 2017 · 127 citations · Full text

Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial

John H. Krystal, John M. Kane, Christoph U. Correll et al. · The Lancet · 2022 · 105 citations

, , +7

Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia

John M. Kane, Timothy Peters-Strickland, Ross A. Baker et al. · The Journal of Clinical Psychiatry · 2014 · 103 citations · Full text

Rows per page

1–5 of 19